Blood Journal
Leading the way in experimental and clinical research in hematology

Supplemental Table

Supplemental materials for: Reese et al

Files in this Data Supplement:

  • Table S1. Results of analyses of the 1,468 drugs evaluated by case reports, laboratory analysis, and/or data mining of the AERS database (PDF, 679 KB) -

    All 1468 individual drugs are listed with the results of their assessment by clinical data from published case reports, laboratory detection of drug-dependent antibodies, or by data mining of the AERS database. The symbol + indicates evidence for a causal association with thrombocytopenia by analysis of published case reports, documentation of a drug-dependent platelet reactive antibody, or a statistically significant reporting association by data mining; - indicates drugs described in case reports but clinical data did not support evidence for a causal association with thrombocytopenia, drugs that were submitted for laboratory testing for drug-dependent antibodies but none were identified, or were reported to the AERS database as a possible cause of thrombocytopenia but no statistical reporting association was determined by data mining; 0 indicates drugs not described in case reports, not submitted for laboratory testing for drug-dependent antibodies, or not reported to the AERS in association with thrombocytopenia.